Plastic bag shortage a hefty problem for Novavax's COVID-19 vaccine production push

A shortage of large, sterile plastic bags used to grow vaccine cells has hobbled Novavax's work to scale up its COVID-19 shot production.

CEO Stan Erck told the Observer that the shortage of the 2,000-liter bags is a threat to the global supply of vaccines.

In late March, a European Union official told Reuters that Novavax had delayed signing a contract to supply COVID-19 vaccines to the EU because it was struggling to secure some raw materials.

Plastic bag shortage a hefty problem for Novavax's COVID-19 vaccine production push

https://www.fiercepharma.com/manufacturing/lack-grow-bags-a-hefty-problem-for-novavax-s-covid-19-vaccine-production-push#:~:text=A%20shortage%20of%20large%2C%20sterile,its%20COVID%2D19%20shot%20production.&text=Gaithersburg%2C%20Maryland%2Dbased%20Novavax%20had,100%20million%20doses%20next%20year.